Val Gebski
机构: NHMRC Clinical TRials Centre, University of Sydney
每年引用次数
引用次数
引用: 63,460
H-指数: 98
I10-指数 : 352
出版物: 760
Toxicity-adjusted dose (TAD) administration of chemotherapy: Effect of baseline and nadir neutrophil count in patients with breast, ovarian, and lung cancer?
A. Carus , F. Donskov , V. Gebski , R. Kefford
Journal of Clinical Oncology 29
1
2011
P1.07-018 A Meta-Analysis of PD-L1 Expression as a Biomarker of PD-1 Blockade in Advanced Non-Small Cell Lung Cancer
J. Man , V. Gebski , A. Mulvey , R. Hui
Journal of Thoracic Oncology 12 ( 11) S2002 -S2003
1
2017
18LBA A GCIG randomized phase III study of carboplatin (C) & pegylated liposomal doxorubicin (PLD) (C-D) vs carboplatin (C) & paclitaxel (P) (C-P): CALYPSO results in partially platinum-sensitive ovarian cancer (OC) patients
P. Vasey , R. Largillier , M. Gropp , V. Gebski
Ejc Supplements 7 ( 3) 11
7
2009
6001 International randomised phase III study of capecitabine (Cap), bevacizumab (Bev) and mitomycin C (MMC) in first line treatment of metastatic colorectal cancer (mCRC): final results of the AGITG MAX trial
N. Tebbutt , V. Gebski , K. Wilson , M. Cummins
Ejc Supplements 7 ( 2) 321
2
2009
6539 The difference in standardized uptake value on 18F-FDG-PET before and after pre-operative chemotherapy is a prognostic factor for recurrence and survival in patients with gastroesophageal cancer
F. Chionh , D. Handolias , A. Poon , V. Gebski
Ejc Supplements 7 ( 2) 373
2009
Kilovoltage Intrafraction Monitoring (KIM) Real-Time Tracking Improves Patient Dose Distributions: Interim Primary Hypothesis Results from the First 20 Patients on the TROG 15.01 Stereotactic Prostate Ablative Radiation Therapy SPARK Trial
E.A. Hewson , D.T. Nguyen , R. O'Brien , P.R. Poulsen
International Journal of Radiation Oncology Biology Physics 102 ( 3)
2018
Tumor Depth of Invasion vs Tumor Thickness in Determining Risk of Nodal Disease in Early Oral Tongue Squamous Cell Carcinoma
B. Liu , R. Amaratunga , M. Veness , E. Wong
International Journal of Radiation Oncology Biology Physics 102 ( 3)
3
2018
Left-Sided Breast Cancer Locoregional Radiation Therapy With Deep Inspiration Breath Hold (DIBH): Does Volumetric Modulated Arc Therapy (VMAT) Reduce the Cardiac Dose Further When Compared to Tangential Intensity Modulated Radiation Therapy (T-IMRT)?
T.T. Pham , R. Ward , D. Latty , C. Owen
International Journal of Radiation Oncology Biology Physics 90 ( 1)
2014
Health-related quality of life (HRQL) and progression-free survival (PFS) in patients with recurrent ovarian cancer: Results from the CALYPSO trial.
M Brundage , M Gropp , F Mefti , K Mann
Journal of Clinical Oncology 28 5044 -5044
2010
Patient-rated outcomes (PRO) in a randomized trial of first-line chemotherapy with capecitabine (C), bevacizumab (B), and mitomycin-C (M) for metastatic colorectal cancer: The AGITG MAX trial.
M. Stockler , D. Zannino , K. Wilson , V. Gebski
Journal of Clinical Oncology 28
1
2010
Disparities starting adjuvant chemotherapy for locally advanced cervix cancer in the international, academic, randomised, phase III OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274)
L. Mileshkin , E. Barnes , K.N. Moore , V. Gebski
Annals of Oncology 30
2019
Oesophageal cancer: outcome of modern surgical management.
I. O'Rourke , N. Tait , C. Bull , V. Gebski
Australian and New Zealand Journal of Surgery 65 ( 1) 11 -16
25
1995
PROGNOSTIC SIGNIFICANCE OF C-ERBB-2 ONCOGENE IN AXILLARY NODE-NEGATIVE BREAST CANCER
J. G. Molland , B. H. Barraclough , V. Gebski , J. Milliken
Australian and New Zealand Journal of Surgery 66 ( 2) 64 -70
17
1996
Tongue cancer: do patients younger than 40 do worse?
DM Hyam , RC Conway , Y. Sathiyaseelan , V. Gebski
Australian Dental Journal 48 ( 1) 50 -54
36
2003
Internal mammary lymph node metastasis in breast cancer: predictive models to assist with prognostic influence.
F. Noushi , A.J. Spillane , R.F. Uren , V. Gebski
The Breast 20 ( 3) 278 -283
15
2011
Identification of the Sentinel Lymph Node in the SNAC-1 Trial
A. Elmadahm , P. Gill , M. Bochner , V. Gebski
The Breast 23 ( 4)
2014
Factors predicting the nodal involvement in early breast cancer
A. Elmadahm , P. Gill , G. Farshid , V. Gebski
The Breast 23 ( 4)
2014
AUSTRALASIAN GASTRO-INTESTINAL TRIALS GROUP. SURVIVAL BENEFI TS FROM NEOADJUVANT CHEMORADIOTHERAPY OR CHEMOTHERAPY IN OESOPHAGEAL CARCINOMA: A META-ANALYSIS
V Gebski , B Burmeister , BM Smithers ,
LANCET ONCOLOGY 8 226 -234
236
2007
Oxygen saturation and neurodevelopment in 1135 preterm infants: the NHMRC Boost II trial
V Gebski , L Doyle , A Kirby , M Luig
19th Annual Meeting of the Perinatal Society of Australia and New Zealand
2015
Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer.
C K Lee , H Gurney , C Brown , R Sorio
British Journal of Cancer 105 ( 3) 360 -365
21
2011